The US Centers for Medicare and Medicaid Services is preparing to enact its breakthrough device reimbursement pathway, Transitional Care for Emerging Technologies.
In an article published last month in the Journal of the American Medical Association, CMS chief strategy officer for coverage Steven Farmer laid out a list of TCET objectives and actions CMS plans to take to fulfill those needs
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?